Adagene Inc. (ADAG) Form 10-Q Quarterly Reports
Adagene Inc. (ADAG) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ADAG
CIK: 1818838
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers Zhong Tian LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerTony Zheng
Audit LocationShanghai, China
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113397 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | OWNERSHIP DOCUMENT | 0001104659-26-111069 | View SEC Doc Filr Page |
| 6-K | 2026-09-25 | 2026-09-25 | FORM 6-K | 0001104659-26-110982 | View SEC Doc Filr Page |
| 6-K | 2026-09-22 | 2026-09-22 | FORM 6-K | 0001104659-26-109485 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-16 | OWNERSHIP DOCUMENT | 0001104659-26-108386 | View SEC Doc Filr Page |
| 6-K | 2026-09-10 | 2026-09-10 | FORM 6-K | 0001104659-26-106554 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | FORM 6-K | 0001104659-26-106137 | View SEC Doc Filr Page |
| 144/A | 2026-08-20 | — | 144/A Filing | 0001104659-26-099289 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0002108105-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | OWNERSHIP DOCUMENT | 0001104659-26-098426 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | OWNERSHIP DOCUMENT | 0001104659-26-097996 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | OWNERSHIP DOCUMENT | 0001104659-26-097995 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | OWNERSHIP DOCUMENT | 0001104659-26-097994 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001678057-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | PRIMARY DOCUMENT | 0002120696-26-000002 | View SEC Doc Filr Page |
| 6-K | 2026-08-12 | 2026-06-30 | 6-K | 0001104659-26-094468 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-06 | OWNERSHIP DOCUMENT | 0001104659-26-092176 | View SEC Doc Filr Page |
| 6-K | 2026-07-06 | 2026-07-06 | FORM 6-K | 0001104659-26-080580 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-08 | — | SCHEDULE 13D/A Filing | 0001104659-26-071145 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001678057-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-07 | — | SCHEDULE 13G Filing | 0001274173-26-000109 | View SEC Doc Filr Page |
| 6-K | 2026-04-17 | 2026-04-17 | FORM 6-K | 0001104659-26-044885 | View SEC Doc Filr Page |
| 424B5 | 2026-04-02 | — | 424B5 | 0001104659-26-039189 | View SEC Doc Filr Page |
| 6-K | 2026-04-02 | 2026-04-02 | FORM 6-K | 0001104659-26-038868 | View SEC Doc Filr Page |
| 424B5 | 2026-04-02 | — | 424B5 | 0001104659-26-038861 | View SEC Doc Filr Page |